158 related articles for article (PubMed ID: 15734419)
21. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.
Chen CJ; Lee BF; Yao WJ; Cheng L; Wu PS; Chu CL; Chiu NT
AJR Am J Roentgenol; 2008 Aug; 191(2):475-9. PubMed ID: 18647920
[TBL] [Abstract][Full Text] [Related]
22. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
Miwa K; Inubushi M; Wagatsuma K; Nagao M; Murata T; Koyama M; Koizumi M; Sasaki M
Eur J Radiol; 2014 Apr; 83(4):715-9. PubMed ID: 24418285
[TBL] [Abstract][Full Text] [Related]
23. Visual and semiquantitative analysis of 18F-fluorodeoxyglucose positron emission tomography using a partial-ring tomograph without attenuation correction to differentiate benign and malignant pulmonary nodules.
Skehan SJ; Coates G; Otero C; O'Donovan N; Pelling M; Nahmias C
Can Assoc Radiol J; 2001 Aug; 52(4):259-65. PubMed ID: 11512300
[TBL] [Abstract][Full Text] [Related]
24. Respiratory-gated 18F-FDG PET imaging in lung cancer: effects on sensitivity and specificity.
Daouk J; Leloire M; Fin L; Bailly P; Morvan J; El Esper I; Saidi L; Moullart V; François G; Jounieaux V; Meyer ME
Acta Radiol; 2011 Jul; 52(6):651-7. PubMed ID: 21511870
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules.
Tsushima Y; Tateishi U; Uno H; Takeuchi M; Terauchi T; Goya T; Kim EE
Ann Nucl Med; 2008 Aug; 22(7):571-7. PubMed ID: 18756359
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic Performance of (18)F-Fluorodeoxyglucose in 162 Small Pulmonary Nodules Incidentally Detected in Subjects Without a History of Malignancy.
Calcagni ML; Taralli S; Cardillo G; Graziano P; Ialongo P; Mattoli MV; Di Franco D; Caldarella C; Carleo F; Indovina L; Giordano A
Ann Thorac Surg; 2016 Apr; 101(4):1303-9. PubMed ID: 26822348
[TBL] [Abstract][Full Text] [Related]
27. 11C-Acetate can be used in place of 18F-fluorodeoxyglucose for positron emission tomography imaging of non-small cell lung cancer with higher sensitivity for well-differentiated adenocarcinoma.
Nomori H; Shibata H; Uno K; Iyama K; Honda Y; Nakashima R; Sakaguchi K; Goya T; Takanami I; Koizumi K; Suzuki T; Kaji M; Horio H
J Thorac Oncol; 2008 Dec; 3(12):1427-32. PubMed ID: 19057268
[TBL] [Abstract][Full Text] [Related]
28. Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size.
Nomori H; Cong Y; Sugimura H; Kato Y
Surg Today; 2015 Dec; 45(12):1535-41. PubMed ID: 25673032
[TBL] [Abstract][Full Text] [Related]
29. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma.
Higashi K; Ueda Y; Seki H; Yuasa K; Oguchi M; Noguchi T; Taniguchi M; Tonami H; Okimura T; Yamamoto I
J Nucl Med; 1998 Jun; 39(6):1016-20. PubMed ID: 9627336
[TBL] [Abstract][Full Text] [Related]
30. The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonary lesions.
Huang YE; Pu YL; Huang YJ; Chen CF; Pu QH; Konda SD; Appelbaum DE
Nucl Med Commun; 2010 Nov; 31(11):945-51. PubMed ID: 20739905
[TBL] [Abstract][Full Text] [Related]
31. Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology.
Karam M; Roberts-Klein S; Shet N; Chang J; Feustel P
J Nucl Med; 2008 Sep; 49(9):1429-36. PubMed ID: 18765585
[TBL] [Abstract][Full Text] [Related]
32. Dual-time point FDG PET imaging in the evaluation of pulmonary nodules with minimally increased metabolic activity.
Xiu Y; Bhutani C; Dhurairaj T; Yu JQ; Dadparvar S; Reddy S; Kumar R; Yang H; Alavi A; Zhuang H
Clin Nucl Med; 2007 Feb; 32(2):101-5. PubMed ID: 17242561
[TBL] [Abstract][Full Text] [Related]
33. [Fluorine-18 fluorodeoxyglucose uptake in patients with benign pulmonary nodules].
Yu CH; Wang T; Sun YE; Yao SL; Tian JH; Yin DY
Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):90-2. PubMed ID: 16620664
[TBL] [Abstract][Full Text] [Related]
34. Solitary pulmonary nodules differentiated by dynamic F-18 FDG PET in a region with high prevalence of granulomatous disease.
Huang YE; Lu HI; Liu FY; Huang YJ; Lin MC; Chen CF; Wang PW
J Radiat Res; 2012; 53(2):306-12. PubMed ID: 22374400
[TBL] [Abstract][Full Text] [Related]
35. Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.
Hickeson M; Yun M; Matthies A; Zhuang H; Adam LE; Lacorte L; Alavi A
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1639-47. PubMed ID: 12458399
[TBL] [Abstract][Full Text] [Related]
36. Biopsy findings in PET/CT-positive lung lesions in a community hospital.
Lobrano MB; Hayman E; Dekelbaum M; Campeau R
J La State Med Soc; 2005; 157(6):319-24. PubMed ID: 16579344
[TBL] [Abstract][Full Text] [Related]
37. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
38. Solitary pulmonary nodules: morphological and metabolic characterisation by FDG-PET-MDCT.
Orlacchio A; Schillaci O; Antonelli L; D'Urso S; Sergiacomi G; Nicolì P; Simonetti G
Radiol Med; 2007 Mar; 112(2):157-73. PubMed ID: 17361379
[TBL] [Abstract][Full Text] [Related]
39. Differentiating benign and malignant pulmonary lesions with FDG-PET.
Yang SN; Liang JA; Lin FJ; Kwan AS; Kao CH; Shen YY
Anticancer Res; 2001; 21(6A):4153-7. PubMed ID: 11911310
[TBL] [Abstract][Full Text] [Related]
40. 3'-Deoxy-3'-18F-fluorothymidine as a proliferation imaging tracer for diagnosis of lung tumors: comparison with 2-deoxy-2-18f-fluoro-D-glucose.
Yamamoto Y; Nishiyama Y; Ishikawa S; Gotoh M; Bandoh S; Kanaji N; Asakura M; Ohkawa M
J Comput Assist Tomogr; 2008; 32(3):432-7. PubMed ID: 18520552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
